Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9758125 | 1.00 | TLR4 (0.34) | TLR4CYP1A2 | |
| SCHEMBL9758128 | 1.00 | TLR4 (0.34) | TLR4CYP1A2 | |
| SCHEMBL14329914 | 0.90 | TLR4 (0.33) | TLR4 | |
| SCHEMBL9759349 | 0.89 | TLR4 (0.33) | TLR4 | |
| SCHEMBL9759362 | 0.89 | TLR4 (0.33) | TLR4 | |
| SCHEMBL9759355 | 0.89 | TLR4 (0.33) | TLR4 | |
| SCHEMBL10999531 | 0.87 | CYP1A2 (0.39) | CYP1A2 | |
| SCHEMBL9758255 | 0.87 | CYP1A2 (0.39) | CYP1A2 | |
| SCHEMBL9758251 | 0.87 | CYP1A2 (0.39) | CYP1A2 | |
| SCHEMBL6407432 | 0.86 | TLR4 (0.35) | TLR4CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8778223-B2 | Liquid crystals having cyclohexyl core structures and fluorinated tails | LC VISION, LLC (US) | 2014-07-15 | — | — | US | disclosed |
| US-20120326083-A1 | LIQUID CRYSTALS HAVING CYCLOHEXYL CORE STRUCTURES AND FLUORINATED TAILS | LC VISION, LLC | 2012-12-27 | — | — | US | disclosed |
| US-4985583-A | Liquid Crystals | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1991-01-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120326083-A1 | LIQUID CRYSTALS HAVING CYCLOHEXYL CORE STRUCTURES AND FLUORINATED TAILS | Q6ZSR9, CRACR2A, RCC1 | TLR4 4212/4885CYP1A2 1656/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.